Table 3 Complications and drug-related side effects of iMN patients in two groups during the follow-up period
Complications | Low-level group(n = 52) | High-level group(n = 42) | P value |
|---|---|---|---|
Infection | 11/55 (20%) | 16/45 (35.6%) | 0.065 |
acute kidney injury | 1/52(1.9%) | 1/42(2.4%) | 0.697 |
ESKD | 1/52 (1.9%) | 8/42 (19%) | 0.014 |
Died | 0 (0%) | 3/42 (7.1%) | 0.086 |
Diabetes/glucose intolerance | 6/52 (11.5%) | 7/42(16.7%) | 0.337 |
Thromboembolic complications | 0 (0%) | 0 (0%) | — |